SOUTH EAST ASIA AND SOUTH ASIA INDUSTRIAL MICROBIOLOGY MARKET ANALYSIS

South East Asia and South Asia industrial microbiology market is estimated to be valued at US$ 746.1 Mn in 2023, and is expected to exhibit a CAGR of 6% during the forecast period (2023-2030).

Analysts’ Views on South East Asia and South Asia Industrial Microbiology Market:

Increasing research and development of bioproducts with clean technology by researchers is expected to drive the market growth over the forecast period. For instance, in September 2022, the Center of Excellence in Microbial Technology for Marine Pollution Treatment, Department of Microbiology, Faculty of Science, Chulalongkorn University, Thailand, started researching and developing innovative bioproducts to remove oil contaminants from the sea, aiming to  expand industrial-scale production of phjarmaceutical products for ecological sustainability. The researchers are focusing on developing a variety of products to create effective microbes, test production scalability, and preliminary field test for oil dispersant and degradation capacity.

Figure 1. South East Asia and South Asia Industrial Microbiology Market Share (%), By Product Type, 2023

To learn more about this report, request a free sample copy

South East Asia and South Asia Industrial Microbiology Market– Drivers

• Increasing product launch by market players: Increasing organic growth strategies such as product launch by key market players to expand their product portfolio is expected to drive  the market growth over the forecast period. For instance, on March 09, 2023, Vytrus Biotech, a  company that specializes in active ingredients derived from plant stem cells for the cosmetic industry, launched its latest biotech active PHOTOBIOME - the microbiota photoprotector. Photobiome increased opperunities for a new category of microbial antioxidants by helping the  skin microbiota to photoprotect itself by protecting and nourishing bacteria, and thus, modulating the release of its own natural photo-defense molecules that improves the signs of the photoageing process on the skin.
• Increasing inorganic growth strategies such as agreement by key market players: Increasing inorganic growth strategies such as partnership by key market players is expected to drive the market growth over the forecast period. For instance, in July 2020, Baxter, a medical device company, signed an agreement with VIPUN Medical, a biotechnology company,  to commercialize the VIPUN Gastric Monitoring System. By using a smart enteral feeding tube designed to measure stomach motility, clinicians in the intensive care unit (ICU) and other settings can more accurately identify enteral feeding resistance and make decisions about nutrition therapy.

Figure 2. South East Asia and South Asia Industrial Microbiology Market Share(%), By Region, 2023

To learn more about this report, request a free sample copy

South East Asia and South Asia Industrial Microbiology Market- Regional Analysis

Among region, South East Asia is estimated to hold a dominant position in the South East Asia and South Asia industrial microbiology market over the forecast period. The South East Asia and South Asia industrial microbiology market is expected to witness significant growth in the near future, owing to increasing organic growth strategies such as acquisition by key market players to expand their product portfolio. For instance, in July 2020, PHC Holdings Corporation, a biotechnology company, announced acquisition of the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd. , a medical device company,  to expand its life sciences business across the Asia Pacific region.SciMed (Asia) Pte. Ltd. offers life science products and services including ultra-low temperature freezers and CO₂ incubators in Southeast Asia, India, and Oceania.

South East Asia and South Asia Industrial Microbiology Market– Impact of Coronavirus (COVID-19) Pandemic

• Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization (WHO) declared it a public health emergency on January 30, 2020.
• COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of things from one place to another.
• However, the emergence of the COVID-19 pandemic had a significant impact on the global economy, which not only impacted the healthcare sector but other sectors too. The restrictions imposed by respective governments across the world to curb the spread of infections led to disruption in services like manufacturing, sample testing, research, and development activities other than COVID-19, pharmaceutical and biotechnology supply chain, and this had negative impact on the South East Asia and South Asia industrial microbiology market. For instance, in October 2021, according to the research study publishedtitled “Impact of COVID‐19 on agricultural production and distribution in South Asia”, in India, Bangladesh, and Pakistan, the agriculture sector was severely impacted as the COVID-19 emerged in these regions during harvest time, and thus, production, distribution and other activities were impacted for agriculture and industrial products in these countries.

South East Asia and South Asia Industrial Microbiology Market- Segmentation

South East Asia and South Asia industrial microbiology market is segmented into  product type, testing type, end user, and region.

• By product type, the market is segmented into Equipment & system (filtration pumps & systems, microbial detection systems, air monitoring systems, incubators & culture apparatus, and others), reaction consumables (media (simple media, complex media, defined media, and specialty media), reagents & stains, and others), and laboratory supply (bags & bottles, loop & needles, petrifies, racks, seals, plates & holders, sample preparation & collection, filtration discs and membranes, and others). Out of which, equipment & system is expected to hold a dominant position in the South East Asia and South AsiaiIndustrial microbiology market during the forecast period due to increasing resaerch and development activities by key market players.
• By testing type, the market is segmented into sterility testing (open system, closed system, RTU bottles, DCM), bio-burden Ttesting (membrane, funnels), environmental testing (RTU plates, DCM, hygiene monitoring in food, air samplers, compressed gas monitoring), pyrogen testing, pathogen testing (traditional method, rapid (platform)), and others). Out of which, environmental testing is expected to dominate the market over the forecast period due to increasing growth strategies such as partnership by key market players.
• By end user, the market is segmented into pharmaceuticals & biotechnology industry, government, academia, food and beverage industry, testing labs/commercial labs, and others. Out of which,  pharmaceuticals & biotechnology industry is expected to dominate the market over the forecast period due to the increasing use of microbiology instruments in pharmaceuticals & biotechnology industry.
• By region, the market is segmented into South East Asia and South Asia. Out of which, South East Asia is expected to dominate the market over the forecast period due to the increasing growth strategies such as acquisition by the key market players.
• Among all the segmentation, the product type segment is expected to dominate the market over the forecast period due to increasing investment funding by key market players to expand their product portfolio. For instance, in May 2022, Merck KGaA, a leading science and technology company, expanded its membrane and filtration manufacturing capabilities in Ireland. The company invested approximately US$ 464 Mn (€440 Mn) to increase membrane manufacturing capacity in Carrigtwohill, and in building a new manufacturing facility at Blarney Business Park, both in Cork, Ireland.

South East Asia and South Asia Industrial Microbiology Market- Cross Sectional Analysis

Key market players are focusing on organic growth strategies such as product launch to expand their product portfolio, and this is expected to drive the South East Asia and South Asia industrial microbiology market in South East Asia region. For instance, in August 2022, International Water Management Institute (IWMI), an international  research-for-development organization, announced the launch of South Asia Drought Monitoring System (SADMS), aimed at addressing the existing and potential challenges to drought management, and providing a framework for proactive drought mitigation measures across nations in South East Asia region.

South East Asia and South Asia Industrial Microbiology Market: Key Developments

• On June 29, 2023, Merck KGaA, a leading science and technology company,  announced that it had invested US$ 70 Mn for expanding production capacity for highly-purified reagents at its site in Nantong, China, to overcome increased demand for high-quality products and a more resilient supply chain.
• On May 03, 2023, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, a leading science and technology company, announced that the Life Science business sector had signed a non-binding Memorandum of Understanding (MoU) with the Ministry of Trade, Industry and Energy (MOTIE), and Daejeon City, India for a new Asia Pacific BioProcessing Center, aimed at supporting the region’s healthcare eco-system. The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia Pacific.
• In June 2022, STEMart, a provider of integrated medical device and diagnostic clinical development, introduced comprehensive microbiology and sterility testing for sterile and  non-pyrogenic products. STEMart has extensive expertise in microbiology as well as sterility testing and remains dedicated to a full-service experience that supports manufacturers in meeting regulatory goals and minimizing compliance risk.
• In April 2022, Hygiena LLC,  a microbiology and life science company, launched a new, ultra-rapid, microbial screening kit named RapiScreen Beverage Kit that provides high-performance testing for low pH beverages using Innovate System. The kit provides quality control results in less than 30 minutes following a preliminary incubation period, allowing manufacturers to confirm product quality for quick release to market.
• In May 2021, Thermo Fisher Scientific Inc., a biotechnology company, launched first-in-market CO₂ incubator that combines optimal cell growth capabilities with certified cleanroom compatibility, and thus, effectively addressing the growing need among biotechnology, biopharmaceutical, and clinical laboratories for high-performance incubation systems that meet stringent cleanroom and cGMP standards.
• In March 2021, PHC Holdings Corporation, a biotechnology company, launched New IncuSafe Cell Culture Incubators MCO-50AIC & MCO-50M to provide precise control of CO₂ concentrations and accurate, uniform, and highly responsive temperature control within the chamber.

South East Asia and South Asia Industrial Microbiology Market: Key Trends

• Increasing organic growth strategies such as facility expansion: Increasing organic growth strategies such as facility expansion by key market players to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, on July 12, 2023, Merck KGaA, a leading science and technology company, announced the expansion of its facility in Lenexa, Kansas, U.S. adding 9,100 sq m2 of lab space and production capability to manufacture cell culture media to meet current demand and ensure supply robustness for future demand surges.

South East Asia and South Asia Industrial Microbiology Market: Restraint

• Lack of skilled professionals: The factors such as high risk of contamination for media and end products and lack of skilled professionals are expected to hamper the growth of the South East Asia and South Asia industrial microbiology market over the forecast period. For instance, in May 2021, according to data provided by The Organization for Economic Co-operation and Development, an international organization, the importance of reducing skill imbalances for productivity and employment growth has been acknowledged in many countries, including in the Southeast Asia region. In Malaysia, the government stated in its 2017/18 Economic Report that “Skill shortages and mismatches in the workforce are among the major challenges in boosting productivity” (Ministry of Finance, 2018[13])., Cambodia’s National Employment Policy 2015-2025 points towards skills shortages as a constraint to innovation and firm growth.
• Counterbalance: Key players are focusing on expanding capacity to train the professional,  and this is expected to drive the market growth over the forecast period.

South East Asia and South Asia Industrial Microbiology Market- Key Players

Major players operating in the South East Asia and South Asia industrial microbiology market include Merck KGaA., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Asiagel Corporation, Eppendorf AG, BioMérieux SA, Danaher Corporation, QIAGEN, Sartorius AG, 3M, HiMedia Laboratories Pvt. Ltd., Hygiena, LLC, Avantor, Inc., Advanced Diagnostic Laboratory (ADL), and BioLab Diagnostics India Private Limited.

Definition: Industrial microbiology is a branch of biotechnology that applies microbial sciences to create industrial products in mass quantities, often using microbial cell factories. There are multiple ways to manipulate a micro-organism in order to increase maximum product yields.